Author
Listed:
- Sho Kubota
(Kumamoto University)
- Kenji Tokunaga
(Kumamoto University)
- Tomohiro Umezu
(Tokyo Medical University)
- Takako Yokomizo-Nakano
(Kumamoto University)
- Yuqi Sun
(Kumamoto University)
- Motohiko Oshima
(Chiba University
The University of Tokyo)
- Kar Tong Tan
(National University of Singapore)
- Henry Yang
(National University of Singapore)
- Akinori Kanai
(Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University)
- Eisaku Iwanaga
(Kumamoto University)
- Norio Asou
(Saitama Medical University)
- Takahiro Maeda
(Nagasaki University, Graduate School of Biomedical Science)
- Naomi Nakagata
(Kumamoto University)
- Atsushi Iwama
(Chiba University
The University of Tokyo)
- Kazuma Ohyashiki
(Tokyo Medical University)
- Motomi Osato
(National University of Singapore
Kumamoto University
Kumamoto University)
- Goro Sashida
(Kumamoto University)
Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of acute leukemia, the cell of origin of which is considered to be precursors of plasmacytoid dendritic cells (pDCs). Since translocation (6;8)(p21;q24) is a recurrent anomaly for BPDCN, we demonstrate that a pDC-specific super-enhancer of RUNX2 is associated with the MYC promoter due to t(6;8). RUNX2 ensures the expression of pDC-signature genes in leukemic cells, but also confers survival and proliferative properties in BPDCN cells. Furthermore, the pDC-specific RUNX2 super-enhancer is hijacked to activate MYC in addition to RUNX2 expression, thereby promoting the proliferation of BPDCN. We also demonstrate that the transduction of MYC and RUNX2 is sufficient to initiate the transformation of BPDCN in mice lacking Tet2 and Tp53, providing a model that accurately recapitulates the aggressive human disease and gives an insight into the molecular mechanisms underlying the pathogenesis of BPDCN.
Suggested Citation
Sho Kubota & Kenji Tokunaga & Tomohiro Umezu & Takako Yokomizo-Nakano & Yuqi Sun & Motohiko Oshima & Kar Tong Tan & Henry Yang & Akinori Kanai & Eisaku Iwanaga & Norio Asou & Takahiro Maeda & Naomi Na, 2019.
"Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm,"
Nature Communications, Nature, vol. 10(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09710-z
DOI: 10.1038/s41467-019-09710-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09710-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.